Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors

被引：19

作者：

Gilbert, JA ^{[1
]}

Lloyd, RV ^{[1
]}

Ames, MM ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 02期

关键词：

D O I：

10.1056/NEJM200507143530219

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：209 / 210

页数：2

共 4 条

[1] A novel approach in the treatment of neuroendocrine gastrointestinal tumours.: Targeting the epidermal growth factor receptor by gefitinib (ZD1839) [J].

Höpfner, M ;

Sutter, AP ;

Gerst, B ;

Zeitz, M ;

Scherübl, H .

BRITISH JOURNAL OF CANCER, 2003, 89 (09) :1766-1775

[2] Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy [J].

Howe, MC ;

Chapman, A ;

Kerr, K ;

Dougal, M ;

Anderson, H ;

Hasleton, PS .

HISTOPATHOLOGY, 2005, 46 (02) :195-201

[3] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[4] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

← 1 →